Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.904 USD | +2.26% | +4.10% | +2.26% |
Feb. 14 | Transcript : Aytu BioPharma, Inc., Q2 2024 Earnings Call, Feb 14, 2024 | |
Feb. 14 | Earnings Flash (AYTU) AYTU BIOPHARMA Reports Q2 Revenue $22.9M, vs. Street Est of $21.75M | MT |
Financials (USD)
Sales 2024 * | 83.55M | Sales 2025 * | 77.08M | Capitalization | 15.81M |
---|---|---|---|---|---|
Net income 2024 * | -12M | Net income 2025 * | 2M | EV / Sales 2024 * | 0.19 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.21 x |
P/E ratio 2024 * |
-1.27
x | P/E ratio 2025 * |
5.68
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.51% |
Latest transcript on Aytu BioPharma, Inc.
1 day | +2.26% | ||
1 week | +4.10% | ||
Current month | -4.46% | ||
1 month | -5.70% | ||
3 months | +1.91% | ||
6 months | -0.20% | ||
Current year | +2.26% |
Managers | Title | Age | Since |
---|---|---|---|
Joshua Disbrow
CEO | Chief Executive Officer | 49 | 15-04-15 |
Jarrett Disbrow
FOU | Founder | 49 | 15-04-15 |
Mark Oki
DFI | Director of Finance/CFO | 55 | 22-01-16 |
Members of the board | Title | Age | Since |
---|---|---|---|
Vivian Liu
BRD | Director/Board Member | 62 | 22-06-30 |
Jarrett Disbrow
FOU | Founder | 49 | 15-04-15 |
Joshua Disbrow
CEO | Chief Executive Officer | 49 | 15-04-15 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 2.904 | +2.26% | 6 107 |
24-04-25 | 2.84 | +1.43% | 8,003 |
24-04-24 | 2.8 | +3.13% | 13,960 |
24-04-23 | 2.715 | -3.37% | 9,066 |
24-04-22 | 2.81 | +0.71% | 6,647 |
Delayed Quote Nasdaq, April 26, 2024 at 12:24 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.26% | 15.81M | |
+25.76% | 653B | |
+27.00% | 556B | |
-6.56% | 354B | |
+20.44% | 331B | |
+2.96% | 296B | |
+13.09% | 233B | |
+5.46% | 201B | |
-9.61% | 193B | |
-5.93% | 144B |
- Stock Market
- Equities
- AYTU Stock